The Global Implantable Cardiac Monitor Market was valued at USD 521.41 million in 2019 and is predicted to reach USD 1 billion by 2030 with a CAGR of 6.1% from 2020-2030. The implantable cardiac monitor is also known as the implantable loop recorder. These are small devices that can be inserted into the human body for continuously monitoring their heart beats. They have the ability to not only monitor but also to evaluate and report the inconsistent and unexplained arrhythmias. The increasing prevalence of cardiac arrhythmias such as atrial fibrillation and bradycardia has boosted the demand for implantable cardiac monitor market globally. Market Segmentations and Scope of the Study: The implantable cardiac monitor market is segmented into indication, end user and geography. On the basis of indication, the market is segmented into cardiac arrhythmias, atrial fibrillation, epilepsy and unexplained falls. On the basis of end user, the market is segmented into hospitals, cardiac centers & clinics, and ambulatory surgery centers. Based on geography the market is segmented into North America, Europe, Asia Pacific and RoW. Request for a free sample- https://www.nextmsc.com/Implantable-Cardiac-MonitorMarket/request-sample Geographical Analysis: The North American region is anticipated to hold the lion share of the market during the forecast period. This is attributable to the factors including high adoption rate of technologically advanced implantable cardiac monitors, the presence of major key healthcare companies, high consumer awareness, and favorable reimbursement framework. However, Asia Pacific region is expected to show rapid and consistent growth in terms of market share within the forecast period owing to factors such as increasing prevalence of atrial fibrillation, rise in obesity, and growing geriatric population. Inquire
before
buying-
https://www.nextmsc.com/Implantable-Cardiac-Monitor-
Market/inquire-before-buying Competitive Landscape: Lucrative growth opportunities make the implantable cardiac monitor market extremely competitive. Some of the major players in the market are Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Edwards Lifescience Corporation, General Electric Company, Koninklijke Philips N.V., LivaNova PLC, Medtronic plc, Nihon Kohden Corporation and Phoenix Heart Center. Strategic alliances, acquisitions and innovations along with R&D are key strategies used by the market players to maintain market dominance.
About Us: Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics. We carefully analyse the historical data, augment it by constantly keeping an eye on the latest industry trends and estimate the future events to arrive at accurate market forecasts. For more insights, please visit, https://www.nextmsc.com
Tags: #implantablecardiacmonitormarketsize
#implantablecardiacmonitormarketshare
#implantablecardiacmonitormarketanalysis #implantablecardiacmonitormarketgrowth